Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.

Hyams, Catherine; Challen, Robert; Marlow, Robin; Nguyen, Jennifer; Begier, Elizabeth; Southern, Jo; King, Jade; Morley, Anna; Kinney, Jane; Clout, Madeleine; Oliver, Jennifer; Gray, Sharon; Ellsbury, Gillian; Maskell, Nick; Jodar, Luis; Gessner, Bradford; McLaughlin, John; Danon, Leon; Finn, Adam

Hyams, Catherine; Challen, Robert; Marlow, Robin; Nguyen, Jennifer; Begier, Elizabeth; Southern, Jo; King, Jade; Morley, Anna; Kinney, Jane; Clout, Madeleine; Oliver, Jennifer; Gray, Sharon; Ellsbury, Gillian; Maskell, Nick; Jodar, Luis; Gessner, Bradford; McLaughlin, John; Danon, Leon; Finn, Adam.

Afiliação

Hyams C; Population Health Sciences, University of Bristol, Bristol, UK.
Challen R; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Marlow R; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Nguyen J; Engineering Mathematics, University of Bristol, Bristol, UK.
Begier E; Population Health Sciences, University of Bristol, Bristol, UK.
Southern J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
King J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Morley A; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Kinney J; Vaccine and Testing Team, Clinical Research Facility, UHBW NHS Trust, Bristol, UK.
Clout M; Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, UK.
Oliver J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Gray S; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Ellsbury G; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Maskell N; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Jodar L; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Gessner B; Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, UK.
McLaughlin J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Danon L; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Finn A; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.

Lancet Reg Health Eur ; 25: 100556, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36530491

Palavras-chave

COVID-19; Respiratory infection; SARS-CoV-2; Vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Reg Health Eur Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google